Gut Microbiota Research & Practice is a section dedicated to promoting knowledge-sharing and debate among researchers, scientists and healthcare professionals. You will find a selection of discussions about articles from scientific literature as well as other content including interviews with experts, event reports, and special publications.

Bifidobacteria colonization in newborns

5 Aug 2015

by GMFH Editing Team

Bifidobacteria is a key marker of a healthy gut flora in infants. A Brazilian study of 49 newborns -- 24 full-term and 25 pre-term (31.2 weeks) -- explored the prevalence and concentration of bifidobacteria in stools of one-month-old newborns using qPCR.

Millions of colonoscopies are performed each year in the United States and Europe. In the days following colonoscopy, up to one fifth of patients experience abdominal pain.

A systematic review and meta-analysis of randomized clinical trials confirmed the efficacy of different probiotics, either in capsule form or in yogurt or drinks, to control hyperglycaemia, hyperinsulinemia, and insulin resistance in patients suffering from diabetes.

Differences in the composition of gut microbiota in health and disease are providing new ways of deciphering mechanisms of digestive diseases, e.g. inflammatory bowel disease (IBD). Another way of exploring the role of gut microbiota in health and disease is to monitor the generated metabolites.

Digestive disorders, from gut discomfort to inflammatory bowel diseases (IBD) and cancer, are rising in many countries. Research and clinical studies on the interaction of gut microbiota and digestive health, are providing stimulating data. However, their connection is not fully understood and gut fungi have recently been suggested to play a role as well.

Go to Top